We're riding for our friend and colleague, Matt Bencke, the founding CEO of Mighty AI, who was was diagnosed with pancreatic cancer just weeks before the 2017 Obliteride, and lost his battle less than three months later.
OUR COMMITMENT TO CURING CANCER FASTER STARTS HERE.
CURES START HERE.
DISCOVERY STARTS HERE. COMMUNITY STARTS HERE.
HEALING STARTS HERE.
OUR RIDE STARTS HERE
We are committing to ride Obliteride this August because we believe research is the fastest path to curing cancer and we also believe the team at Fred Hutch can get us there.
Sadly, half of all men and one third of all women in the U.S. will get cancer in their lifetime.
Fred Hutch is learning more about cancer prevention, diagnostics and treatment and Obliteride can help us get to cures faster.
More than 300 labs and projects are working hard to save the lives of people all over the world by conducting innovative, high-impact cancer research.
Please join us in this effort to put cancer in its place, behind us.
Ride with us, donate to our team, and tell others about Obliteride.